Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
$810M |
| 2 |
Intuitive Surgical
ISRG
|
$705M |
| 3 |
S&P Global
SPGI
|
$439M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$361M |
| 5 |
Bristol-Myers Squibb
BMY
|
$253M |
Top Sells
| 1 |
Broadcom
AVGO
|
$605M |
| 2 |
FedEx
FDX
|
$587M |
| 3 |
Monster Beverage
MNST
|
$395M |
| 4 |
McDonald's
MCD
|
$387M |
| 5 |
Booking.com
BKNG
|
$380M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 16.25% |
| 3 | Healthcare | 15.51% |
| 4 | Financials | 12.99% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Capital One
COF
$142B
| $92.8M | 0.09% |
977,215
-4,871
| -0.5% | -$462K |
|
152
Hexcel
HXL
$5.16B
| $92.7M | 0.09% |
1,382,736
-70,776
| -5% | -$4.75M |
|
|
HRC
153
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $92.4M | 0.09% |
978,335
+312,771
| +47% | +$29.5M |
|
154
Assembly Biosciences
ASMB
$183M
| $92M | 0.08% |
206,432
+464
| +0.2% | +$207K |
|
|
PRAH
155
DELISTED
PRA Health Sciences, Inc.
PRAH
| $91.9M | 0.08% |
834,150
+208,156
| +33% | +$22.9M |
|
156
Teleflex
TFX
$5.78B
| $91.4M | 0.08% |
343,616
+117,279
| +52% | +$31.2M |
|
157
Affiliated Managers Group
AMG
$6.54B
| $91.2M | 0.08% |
667,221
-72,643
| -10% | -$9.93M |
|
158
Starwood Property Trust
STWD
$7.56B
| $91.1M | 0.08% |
4,232,813
-1,442,311
| -25% | -$31M |
|
159
Exact Sciences
EXAS
$10.2B
| $91M | 0.08% |
1,152,986
+186,726
| +19% | +$14.7M |
|
160
Lazard
LAZ
$5.32B
| $90.7M | 0.08% |
1,885,456
-142,048
| -7% | -$6.84M |
|
|
TGE
161
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $89.9M | 0.08% |
3,811,550
+1,116,770
| +41% | +$26.3M |
|
162
CBRE Group
CBRE
$48.9B
| $89.3M | 0.08% |
2,025,630
-457,803
| -18% | -$20.2M |
|
163
PPL Corp
PPL
$26.6B
| $88.6M | 0.08% |
3,029,446
-8,081
| -0.3% | -$236K |
|
164
TC Energy
TRP
$53.9B
| $88.5M | 0.08% |
2,186,985
-244,200
| -10% | -$9.88M |
|
165
Analog Devices
ADI
$122B
| $88.5M | 0.08% |
956,738
-162,706
| -15% | -$15M |
|
166
Five Below
FIVE
$8.46B
| $87.9M | 0.08% |
676,040
-639,179
| -49% | -$83.1M |
|
167
Flex
FLEX
$20.8B
| $87.3M | 0.08% |
8,829,693
-2,133,885
| -19% | -$21.1M |
|
168
Natera
NTRA
$23.1B
| $87.2M | 0.08% |
3,641,848
+1,024,225
| +39% | +$24.5M |
|
|
NVRO
169
DELISTED
NEVRO CORP.
NVRO
| $85.6M | 0.08% |
1,501,045
-189,720
| -11% | -$10.8M |
|
|
AERI
170
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $85.3M | 0.08% |
1,386,211
+76,390
| +6% | +$4.7M |
|
|
EE
171
DELISTED
El Paso Electric Company
EE
| $85M | 0.08% |
1,485,429
-98,476
| -6% | -$5.63M |
|
172
Idexx Laboratories
IDXX
$51.4B
| $84.6M | 0.08% |
338,870
+213,132
| +170% | +$53.2M |
|
173
XPO
XPO
$15.4B
| $84.6M | 0.08% |
2,142,193
-173,432
| -7% | -$6.85M |
|
174
Hilton Worldwide
HLT
$64B
| $83.9M | 0.08% |
1,038,068
-559,800
| -35% | -$45.2M |
|
175
Performance Food Group
PFGC
$16.5B
| $83.4M | 0.08% |
2,505,074
-24,220
| -1% | -$807K |
|